Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. The company serves cosmetics, consumer packaged and household goods, and nutraceutical industries. Britannia Life Sciences Inc. is headquartered in Toronto, Canada.…
Britannia Life Sciences (CNSX: BLAB) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.
The shares were at 0.0650 CAD on 20 November 2026, down 35.0% over 52 weeks. Its 52-week range is 0.0600 CAD to 0.1100 CAD: the price is 40.9% below the high and 8.3% above the low.
Its market capitalisation is 10.70M CAD.
Britannia Life Sciences reports return on equity of 70.6%, an operating margin of -357.5% and revenue down 40.3% year over year.
It holds more cash than debt, a net cash position of 12.20M CAD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.
No upcoming events tracked.